Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can the Betatrophin be a Reliable Marker of Insulin Resistance in Normal Weight and Overweight Women With Polycystic Ovary Syndrome?

NCT04448730 is registered in ClinicalTrials.gov with Hatice Akkaya as lead sponsor.

NCT NCT04448730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04448730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can the Betatrophin be a Reliable Marker of Insulin Resistance in Normal Weight and Overweight Women With Polycystic Ovary Syndrome?
Lead sponsor
Hatice Akkaya
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
December 30, 2019
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, polycystic ovary